Neurotech: Cognito Spectris/Zervimesine + Nia SNS + VR [climaxing]
Key Questions
What is the OVERTURE study involving EEG-MRI?
OVERTURE uses EEG-MRI for Cognito Spectris in neurotech advancements. It supports Zervimesine achieving 86% NPI improvement.
How effective is Zervimesine in neuropsychiatric symptoms?
Zervimesine demonstrates 86% improvement in NPI scores. This positions it as a key neurotech therapy alongside Nia for TBI.
What is Nia's role in TBI treatment?
Nia Therapeutics targets TBI with SNS approaches. It complements VR therapies like CogMusT for PD-MCI.
What is CogMusT VR therapy for Parkinson's?
CogMusT VR therapy aids PD-MCI patients, enhancing cognition and motor function. San Antonio neuromodulation supports similar neurotech pivots.
What advancements feature Penn State DBS BrainSense?
Penn State DBS BrainSense and focused US PD ablation improve Parkinson's activity levels. UPenn's CAMIPM MRI integrates metabolic imaging for precision.
OVERTURE EEG-MRI; Zervimesine 86% NPI; Nia TBI; CogMusT VR PD-MCI; San Antonio neuromod; Penn State DBS BrainSense; UPenn CAMIPM MRI; Penn focused US PD ablation.